Introduction: Laparoscopic bilateral adrenalectomy (BAD) is one of the treatments of Cushing's Disease (CD), but its indications and outcome is debated.
Methods: The literature on BAD was reviewed as part of a work performed for the Cushing's disease guideline.
Results: The surgical morbidity of BAD is reported between 10 and 18% and no mortality has been reported in the largest series. Because of the endocrine sacrifice it will be mostly performed after a multidisciplinary team discussion in selected cases of refractory CD (mostly after failure of pituitary surgery and/or medical treatment). It is also frequently discussed in female patients desiring pregnancy. Corticotroph tumor progression occurs in 40% of the patients but is in most patients manageable when detected early by a careful long term monitoring with pituitary MRI and ACTH assays after BAD.
Conclusion: BAD is a safe and effective treatment of CD used in specific situations and requiring long term monitoring.
Keywords: Bilateral adrenalectomy; Corticotroph tumor progression; Cushing’s disease; Hypercortisolemia; Laparascopic adrenalectomy.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.